Biogen (BIIB) weekly volatility increases into Q2 and outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. META
10. TLT

Go back to Biogen (BIIB) weekly volatility increases into Q2 and outlook

Biogen (BIIB) PT Raised to $285 at UBS Following Strong 2Q

July 26, 2017 8:44 AM EDT

UBS raised its price target on Biogen (NASDAQ: BIIB) to $285.00 (from $270.00) while maintaining a Neutral rating following the company's 2Q. BIIB recorded a $284M top-line beat. EPS also came in ahead with a $0.53 beat.

Despite a strong 2Q print, the mid-to-long term outlook... More